We’re an agile health economics and outcomes consultancy that anticipates your needs and exceeds your expectations
What we doÂ
Medical writing
Systematic literature reviews
Rapid and pragmatic literature reviews
Strategic evidence searches
Environmental scans
Recent activities
We’re excited to have co-authored a publication in the BMJ Open Heart Journal assessing the cost-effectiveness of a novel diagnostic device.Â
We’re starting a new research project to understand the factors that lead the National Institute of Care Excellence (NICE) in the UK to accept or reject I-O drug appraisals.
We’re excited to have co-authored a publication in Dermatology and Therapy to appraise and synthesise the published evidence on biological therapies for plaque psoriasis.Â
Our work in numbers
43
total clients
28
billion USD – average client turnover
67
% of work conducted with global HQ
Our story
We discover and drive innovative solutions to bring lifesaving treatments to patients around the world.
We work with our clients as a trusted partner and critical friend. Hence our name, Symmetron, from the Greek sym (together) and metron (calculate).
Since 2008, we have been growing steadily in size and capability into a highly-respected source of research in health economics and health outcomes.
Find out more about our successes. Â
We discover and drive innovative solutions to bring lifesaving treatments to patients around the world.
We work with our clients as a trusted partner and critical friend. Hence our name, Symmetron, from the Greek sym (together) and metron (calculate).
Since 2008, we have been growing steadily in size and capability to a highly-respected source of research in health economics and health outcomes.
Find out more about our successes. Â